Udvalget for Humanmedicinske Lægemidler (CHMP) fandt, at Ammonaps effektivt forebygger for høje mængder ammoniak hos patienter med forstyrrelser i urinstofcyklusen.
The Committee for Medicinal products for Human Use (CHMP) decided that Ammonaps effectively prevents ammonia levels to become too high in patients who have urea cycle disorders.